Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer

Authors

  • Pieter Populaire a Department of Radiation Oncology, UZ Leuven, Leuven, Belgium; b Department of Oncology, KU Leuven, Leuven, Belgium
  • Gilles Defraene b Department of Oncology, KU Leuven, Leuven, Belgium
  • Philippe Nafteux c Department of Thoracic Surgery, UZ Leuven, Leuven, Belgium;d Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium
  • Lieven Depypere c Department of Thoracic Surgery, UZ Leuven, Leuven, Belgium;d Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium
  • Johnny Moons c Department of Thoracic Surgery, UZ Leuven, Leuven, Belgium
  • Sofie Isebaert a Department of Radiation Oncology, UZ Leuven, Leuven, Belgium; b Department of Oncology, KU Leuven, Leuven, Belgium
  • Karin Haustermans a Department of Radiation Oncology, UZ Leuven, Leuven, Belgium; b Department of Oncology, KU Leuven, Leuven, Belgium

DOI:

https://doi.org/10.1080/0284186X.2023.2251091

Keywords:

Esophageal cancer, radiation therapy, lung complications, lung function

Abstract

Background

Trimodality treatment, i.e., neoadjuvant chemoradiotherapy (nCRT) followed by surgery, for locally advanced esophageal cancer (EC) improves overall survival but also increases the risk of postoperative pulmonary complications. Here, we tried to identify a relation between dose to functional lung volumes (FLV) as determined by 4D-CT scans in EC patients and treatment-related lung toxicity.

Materials and methods

All patients with EC undergoing trimodality treatment between 2017 and 2022 in UZ Leuven and scanned with 4D-CT-simulation were selected. FLVs were determined based on Jacobian determinants of deformable image registration between maximum inspiration and expiration phases. Dose/volume parameters of the anatomical lung volume (ALV) and FLV were compared between patients with versus without postoperative pulmonary complications. Results of pre- and post-nCRT pulmonary function tests (PFTs) were collected and compared in relation to radiation dose.

Results

Twelve out of 51 EC patients developed postoperative pulmonary complications. ALV was smaller while FLV10Gy and FLV20Gy were larger in patients with complications (respectively 3141 ± 858mL vs 3601 ± 635mL, p = 0.025; 360 ± 216mL vs 264 ± 139mL, p = 0.038; 166 ± 106mL vs 118 ± 63mL, p = 0.030). No differences in ALV dose-volume parameters were detected. Baseline FEV1 and TLC were significantly lower in patients with complications (respectively 90 ± 17%pred vs 102 ± 20%pred, p = 0.033 and 93 ± 17%pred vs 110 ± 13%pred, p = 0.001), though no other PFTs were significantly different between both groups. DLCO was the only PFT that had a meaningful decrease after nCRT (85 ± 17%pred vs 68 ± 15%pred, p < 0.001) but was not related to dose to ALV/FLV.

Conclusion

Small ALV and increasing FLV exposed to intermediate (10 to 20 Gy) dose are associated to postoperative pulmonary complications. Changes of DLCO occur during nCRT but do not seem to be related to radiation dose to ALV or FLV. This information could attribute towards toxicity risk prediction and reduction strategies for EC.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2023-11-02

How to Cite

Populaire, P., Defraene, G., Nafteux, P., Depypere, L., Moons, J., Isebaert, S., & Haustermans, K. (2023). Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer. Acta Oncologica, 62(11), 1488–1495. https://doi.org/10.1080/0284186X.2023.2251091